Skip to main content
. 2019 Mar 6;8:52. doi: 10.1186/s13756-019-0502-x

Fig. 3.

Fig. 3

Kaplan-Meier survival estimates among CRAB-BSI patients with Cefoperazone/Sulbactam therapy. a Kaplan-Meier survival estimates among CRAB-BSI patients with Cefoperazone/Sulbactam monotherapy and Cefoperazone/Sulbactam based combination therapy. b Kaplan-Meier survival estimates among CRAB-BSI patients (APACHE II score < 20) with Cefoperazone/Sulbactam monotherapy and Cefoperazone/Sulbactam based combination therapy. c Kaplan-Meier survival estimates among CRAB-BSI patients (APACHE II score ≥ 20) with Cefoperazone/Sulbactam monotherapy and Cefoperazone/Sulbactam based combination therapy. Abbreviations: CRAB-BSI, Acinetobacter baumannii bloodstream infection; APACHE II score, acute physiology and chronic health evaluation II